$RBII yesterday huge news hit AND stop sign removed! More

New Post Public Reply Private Reply Replies (0) Message Board
BCNstocks
97
$RBII yesterday huge news hit AND stop sign removed! More updates coming >>

Rising Biosciences, Inc. Announces TSW! (This "Stuff" Works!) Topical Pain Cream With CBD To Enter Pilot Production Run, Gov. of Ohio Legalizes Hemp and CBD Products Statewide

https://finance.yahoo.com/news/rising-bioscie...00950.html

SANDUSKY, OH / ACCESSWIRE / August 1, 2019 / Rising Biosciences, Inc. (OTC PINK:RBII) (“Rising Biosciences” or the “Company”) an emerging leader in the research and development of oral and topical pharmaceuticals produced according to the strict standards of the pharmaceutical compounding industry, announces that TSW! (This “stuff” Works!) Topical Pain Relief Cream With CBD (“TSW! Pain Cream CBD”) will enter into pilot production. Rising Biosciences is also excited to announce that TSW! Pain Cream CBD will be available for distribution to markets in its home state of Ohio, due to the passage of a bill on July 30, 2019 which allows legal manufacturing and sale of Hemp and CBD products within the state of Ohio. (https://www.usnews.com/news/best-states/ohio/articles/2019-07-30/dewine-signs-measure-legalizing-hemp-cultivation-in-ohio)

The TSW! Topicals brand, owned exclusively by RBII, is a line of over the counter, topical pain relief products featuring a proprietary blend of clinically proven organic ingredients such as menthol, curcumin, ginger and capsaicin for reducing inflammation and effectively relieving pain. Production of TSW! Topical Pain Relief Cream With CBD is slated for the fall of 2019. The lidocaine based cream, along with the TSW! exclusive blend of natural pain fighting compounds, will contain CBD, a cannabinoid compound derived from cannabis. CBD, unlike its close cousin THC, is non psychoactive and non habit-forming. A growing chorus of clinical researchers attributes exceptional anti-inflammatory and anti-pain properties to CBD. TSW! Pain Cream CBD can be used to fight muscle and joint pain, back pain, neuropathy/nerve pain and arthritis.

“We are particularly gratified to be able to offer TSW! Pain Cream CBD to the market,” explained Art Hall, CEO of Rising Biosciences. “I am thrilled for two reasons:

First of all, I am thrilled because as the name of the product implies, ‘This (“stuff”) Works!’ The number one thing any consumer wants in a pain relief cream is effectiveness, pure and simple. And that’s what TSW! Pain Cream offers like no other competing over the counter product out there. We have tested our proven blend of organic ingredients in numerous consumer trials and the feedback is unanimous, ‘Thanks for producing a pain cream that actually works!’ We have long wanted to add CBD to the formula to make it even more effective, but progress was slowed because of regulatory static we ran into. Now that Governor Mike Devine has signed the bill legalizing the sale of CBD products statewide the field is wide open for us.

Secondly, I am so thrilled because the release of TSW! Pain Cream CBD is in sync with the larger vision of our Company to combat the opioid crisis in the Midwest and beyond. Our own home state of Ohio has been brutalized by this scourge, ranking number two of all US states for opioid overdose deaths. I can only sing the praises of the lawmakers of Ohio for having the vision to join the growing numbers of states who have now fully legalized the manufacture and sale of CBD products. This clears away red tape so we can more effectively treat addiction patients at our SNB Health addiction treatment clinics. It means no more regulatory encumbrance for distributing our Cannophen™ CBD capsules as an opioid addiction treatment alternative in Ohio. And of course it means we can offer TSW! Pain Cream CBD in our own home state as a natural, non addictive, treatment for chronic pain. The sad thing about opioid addiction is that so many sufferers first became hooked when they went to a doctor for pain treatment and were prescribed a synthetic opioid as a solution. This outdated paradigm has led to countless lives ruined by addiction and sadly, a growing epidemic of overdose deaths. It’s entirely preventable. The paradigm needs to change. There are better, non habit forming, non lethal options available for pain management. And that’s what we are offering with TSW! Pain Cream CBD.”

According to Allied Market Research, the global topical pain relief market is projected to reach $13.28 billion by 2025 at a CAGR of 7.4% from 2018 to 2025.

About Rising Biosciences, Inc.

About Rising Biosciences Inc.
- RBII operates three distinct business units. The first business unit is a physicians’ practice management company focused on the proper use of cannabis for the treatment of chronic pain, opioid addiction, and terminal patients. The second business unit is a research and development company focusing on oral and topical pharmaceuticals within the strict standards set forward by the pharmaceutical compounding industry and the FDA. The third business unit offers cutting edge behavioral health medical treatment for substance addiction from branches throughout the Midwest.

Follow $RBII on the NEW Twitter account and on Facebook for LIVE updates!

https://twitter.com/RisingBioscien1
https://www.facebook.com/RisingBioSciences/

CONTACT INFO: For Investor Inquiries: IR@risingbiosciences.com

SOURCE: Rising Biosciences, Inc.
Scroll down for more posts ▼

Top 10 Most Recent News Articles

xTool X1: Redefining Laser Fabrication for Makers

Updated Category News Views 140

The Next Generation of Laser Fabrication Whenever a new gizmo hits the market, it's usually just an upgrade in disguise—faster, shinier, a touch more wattage. Not this time. xTool shook things up by rolling out the X1, a laser platform that gets what small businesses and makers truly crave: versatility and long-lasting potential. This bad boy does more than engrave; it...

Continue Reading
Broadway.com Instagram Reaches Million Followers Milestone

Updated Category News Views 44

Broadway.com's Instagram Ascends to Iconic Status There it is, folks—Broadway.com's Instagram just threw down the gauntlet with a clean, million-follower milestone. That's right, a hefty chunk of people now have a front-row seat to Broadway's electric world, straight from their phones. If you're a Broadway buff or just a casual admirer of glitz and glam, these numbers...

Continue Reading
Chicago's Public Safety Gets Asset Management Overhaul

Updated Category News Views 25

SDI Presence Gives Chicago's Public Safety a Tech Boost When it comes to keeping a city as bustling as Chicago in check, the right tools can make all the difference. Enter SDI Presence, who just gave the city's Public Safety Administration (PSA) a digital makeover through a new Enterprise Asset Management solution on the ServiceNow platform. Streamlining and Centralizing...

Continue Reading
ODNB and NACB Merge: A Big Leap in Community Banking

Updated Category News Views 106

Merging Titans in Community Banking Folks, we've got a colossal merger happening in the cozy yet combative world of community banking—ODNB Financial Corporation is hitching wagons with National Capital Bancorp, Inc. Now, you'd be forgiven for not popping champagne over this unless your bread is buttered by $2.4 billion in assets and the shiny allure of becoming a big...

Continue Reading
Xerox Faces Probes After $130M Profit Forecast Slash

Updated Category News Views 61

When the Trust Breaks October 29, 2026 was a gut punch for Xerox investors. Watching the outlook dive by $130 million, the coffee-feeling in the trading rooms turned into something more bitter. A $105 million boost they once celebrated from tariff receivables now seems to be a fleeting shadow, as Xerox itself scuttles its adjusted operating income for 2026 to a range of...

Continue Reading
Keith Strachan Elevates The Master Group's Strategy

Updated Category News Views 38

Strachan Steps Up as Chief Commercial Officer Keith Strachan is stepping into the role of Chief Commercial Officer at The Master Group—big news up in St-Bruno-de-Montarville. Now, those not neck-deep in HVAC-R might shrug this one off, but for those eyeing the industry, this is where the cards start to shuffle in North America. Master’s shift isn't just paper-pushing;...

Continue Reading
Vuzix to Reveal Q3 2026 Results in Upcoming Call

Updated Category News Views 40

Vuzix Sets the Stage for Its Q3 2026 Earnings Call Out of all the snazzy tech plays you scribble down on a placemat over morning coffee, Vuzix Corporation (NASDAQ: VUZI) is gearing up for some spotlight action. This November 12, at 4:30 PM Eastern Time, they’re unveiling their third quarter 2026 earnings results, piping hot through a conference call. It's the kind of...

Continue Reading
Sweco: Europe’s Water Resilience Faces Tough Challenges

Updated Category News Views 81

Tackling Europe's Water Resilience Ah, water infrastructure—it's that unglamorous pillar we often overlook until nature reminds us of its importance, sometimes with a swift, wet slap across the face. Sweco's recent report might not grab flashy headlines, but it's a good reminder for Europe that smarter investments in water resilience ain't just good advice; it's a damn...

Continue Reading
KLX Energy Refreshes Board with Seasoned Directors

Updated Category News Views 69

A New Chapter for KLX Energy Services KLX Energy Services has just reshuffled its board, and it's stirring interest. With Franklin S. Edmonds, Jr. and E. Dirk Hallen stepping into the roles of independent directors, effective October 29, 2026, there's change in the air. They take over from John Collins and Tom McCaffrey, who've been holding the fort during some...

Continue Reading
FirstEnergy Bolsters Support for Shelter Initiatives

Updated Category News Views 80

FirstEnergy Foundation's Commitment Shines Bright Alright, here's the scoop. FirstEnergy Foundation isn't just about keeping the lights on anymore. They're throwing down $620,000 to tackle one hell of a tough nut—shelter and stability. This latest infusion spreads across five states, with ten nonprofit warriors in New Jersey alone locking in $120,000 of that pot for...

Continue Reading

Top 5 Most Recently Viewed Articles

Uzbekistan's Recent Election Supports Liberal Reforms Move

Updated Category News Views 165

Election Results Signal a Continued Reform Agenda Recently held elections have decisively propelled Uzbekistan’s reform agenda forward. The results released by the Central Election Commission show the Liberal Democratic Party has emerged triumphant, expanding its representation in the Oliy Majlis, the country’s parliament. This significant win solidifies the ongoing...

Continue Reading
Coral Energy Responds to Misleading Claims in Le Monde Article

Updated Category News Views 710

Coral Energy Responds to Misleading Claims in Le Monde Article Recently, Coral Energy has issued a strong statement in response to misleading claims published in a prominent article by Le Monde. The company firmly denies the inaccuracies and unverified allegations presented in the article, which failed to recognize Coral's commitment to compliance and ethical practices....

Continue Reading
Accent Therapeutics' Innovative Trials for Cancer Therapies Unveiled

Updated Category News Views 267

Accent Therapeutics Unveils Promising Cancer Trials Accent Therapeutics has pioneered a Phase 1/2 study for ATX-295, a novel oral inhibitor of KIF18A aimed at tackling advanced solid tumors like ovarian cancer. The FDA has awarded Fast Track designation to Accent's leading clinical candidates, ATX-295 and ATX-559, enhancing their potential to treat adults facing...

Continue Reading
Transforming Education in MENA: Cambridge & HP Launch Fellowship

Updated Category News Views 252

Innovative EdTech Fellowship Unveiled for MENA Leaders In a significant move to enhance education throughout the Middle East and North Africa, Cambridge University Press & Assessment (Cambridge) and HP Inc. have launched a new Education Technology (EdTech) Fellowship. This initiative aims to empower education leaders by integrating advanced technologies, such as...

Continue Reading
AMGEN Unveils Promising Rocatinlimab Results for Atopic Dermatitis

Updated Category News Views 218

Exciting Developments in Atopic Dermatitis Treatment AMGEN is taking monumental steps in the field of dermatology with their recent announcement regarding Rocatinlimab, a drug that shows great promise for those suffering from moderate to severe atopic dermatitis. The results from the Phase 3 IGNITE study underscore a significant advancement in the management of this...

Continue Reading